The EU Response to the Presence of Nitrosamine Impurities in Medicines

The unexpected detection of nitrosamine impurities in human medicines has recently seen global regulators act to understand the risks of these contaminations to patients and to limit their presence. Over 300 nitrosamines are known, many of which are highly potent mutagenic carcinogens. Regulators fi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Robin Ruepp, Roland Frötschl, Robert Bream, Maria Filancia, Thomas Girard, Andrei Spinei, Martina Weise, Rhys Whomsley
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
Accès en ligne:https://doaj.org/article/6cbe2a2b5d95426d9f6833a958105120
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!